Telmisartan Has the Longest Half-Life Among ARBs
Telmisartan possesses the longest terminal half-life of approximately 24 hours among all angiotensin II receptor blockers, making it the optimal choice when sustained 24-hour blood pressure control is the priority 1, 2.
Pharmacokinetic Evidence
Multiple studies consistently identify telmisartan as having superior pharmacokinetic properties compared to other ARBs:
Telmisartan's half-life is approximately 24 hours, which is explicitly stated as "the longest of any of the ARBs" 2. This extended half-life enables sustained blood pressure reductions throughout the entire dosing interval, particularly during the vulnerable early morning hours (6 AM to 12 PM) when cardiovascular events are most likely to occur 1, 3.
The pharmacokinetic profile translates into clinical superiority for end-of-dose blood pressure control. Telmisartan has demonstrated better blood pressure control than valsartan, losartan, ramipril, perindopril, and atenolol, particularly toward the end of the 24-hour dosing interval 1.
Comparative Classification of ARB Half-Lives
ARBs can be categorized by elimination half-life 4:
Shorter-acting ARBs:
- Losartan
- Valsartan
- Eprosartan
Longer-acting ARBs:
- Candesartan
- Irbesartan
- Telmisartan (longest)
Clinical Implications
The extended half-life of telmisartan provides several advantages:
- Superior 24-hour coverage without the blood pressure variability seen with shorter-acting agents
- Protection during the early morning surge when most cardiovascular events (MI, stroke) occur 3
- Potentially improved compliance due to consistent once-daily dosing with reliable coverage
Important Caveat
While telmisartan has the longest half-life, the 2017 ACC/AHA hypertension guidelines 5 list all ARBs as appropriate options without specifically recommending one over another based on half-life alone. The choice should consider the complete clinical picture, including cardiovascular risk profile, tolerability, and specific indications (though you asked specifically about half-life, not overall selection).